The effects of antenatal smoking on lung function and respiratory symptoms in infants and children

Anthony D Milner1, Harish Rao, Anne Greenough

  • 1Division of Asthma, Allergy and Lung Biology, MRC-Asthma Centre, King's College London, King's College Hospital, Denmark Hill, London, SE5 9RS, UK.

Early Human Development
|September 25, 2007
PubMed

Insights

Antenatal smoking exposure significantly increases respiratory issues and abnormal lung function in children. Evidence shows it leads to wheezing, asthma, and altered airway development, impacting infant respiratory health.

Area of Science:

  • Pediatric Pulmonology
  • Environmental Health
  • Developmental Pediatrics

Background:

  • Antenatal smoking exposure is a known risk factor for adverse infant and child respiratory outcomes.
  • Previous studies indicate links to wheezing, asthma, and reduced lung function.

Purpose of the Study:

  • To review evidence on the impact of antenatal smoking on infant and child respiratory health and lung function.
  • To analyze the effects on airway development and bronchial reactivity.

Main Methods:

  • Review of epidemiological studies on respiratory symptoms and lung function in children exposed to smoking in utero.
  • Analysis of animal model data regarding nicotine exposure and lung development.
  • Examination of infant pulmonary function testing results.

Main Results:

  • Consistent evidence links antenatal smoking to increased respiratory symptoms like wheezing and asthma.
  • Lung function tests show reduced airway function and altered airway morphology in exposed children.
  • Animal models demonstrate pulmonary hypoplasia and altered alveolar development; infant lung volume unaffected beyond somatic growth effects.

Conclusions:

  • Antenatal smoking exposure adversely affects infant airway development, leading to respiratory problems.
  • While lung volume may not be directly impacted, airway function is compromised.
  • No evidence suggests increased bronchial hyperreactivity; a diminished response to bronchodilators/constrictors is observed.

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...